Search For "eli lilly and company"
ABL Bio Receives Upfront Payment for License, Research and Collaboration A
Updated : 5 months, 1 week ago IST
Seoul [South Korea], December 26: ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, announced that ABL Bio will receive a USD 40 million upfront payment for the license, research and collaboration agreement for its Grabody platform, and a USD 15 million equity inv
Read More
Piyush Goyal welcomes Eli Lilly's USD 1 billion investment in India
Updated : 7 months, 4 weeks ago IST
US-based pharmaceutical company Eli Lilly and Company has announced plans to invest more than USD one billion in India over the next several years, marking one of the largest foreign investments in the country's healthcare manufacturing sector in recent years. Union Minister of Commerce and
Read More
Eli Lilly plans to invest over USD 1 billion in new contract manufacturing
Updated : 8 months ago IST
In a major decision, US pharma giant Eli Lilly and Company (India) has said that it plans to invest more than $1 billion over the next several years into new contract manufacturing in India, expanding patients' access to innovative medicines aro
Read More
Celltrion signs agreement to buy Eli Lilly's U.S. plant for USD 330 mn
Updated : 8 months ago IST
South Korea's Celltrion Inc. has signed an agreement to acquire Eli Lilly and Company's U.S. biopharmaceutical manufacturing facility, eliminating its tariff-related risks in the U.S. market. The purchase price was USD 330 million, as per a report by Pulse, the English service of Maeil Busi
Read More
Lilly Partners with API to launch 'Obesity Gurukul' - a first-of its-kind
Updated : 8 months ago IST
Eli Lilly and Company (India), in collaboration with the Association of Physicians of India (API), on Friday announced the launch of 'API - Obesity Gurukul', a flagship Continuing Medical Education (CME) program aimed at enhancing physicians' clinical capabilities to address obesity, which
Read More
Weight loss drug Mounjaro shown more effective than Wegovy, claims Pharma
Updated : 1 year ago IST
Eli Lilly and Company announced on Monday detailed results from SURMOUNT-5, a phase 3b open-label clinical trial, evaluating the safety and efficacy of tirzepatide.
Read More
Lilly's orforglipron consistent with injectable GLP-1 medicines in Phase 3
Updated : 1 year, 1 month ago IST
According to an official statement from Eli Lilly and Company, "Orforglipron is the first oral small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist, taken without food and water restrictions, to successfully complete a Phase 3 trial."
Read More
Eli Lilly's antibody cocktail drug gets emergency use nod in India
Updated : 5 years ago IST
New Delhi [India], June 1 (ANI): Eli Lilly and Company India on Tuesday announced that it has received emergency use approval in the country for its monoclonal antibody drug combination used for treating Covid-19 patients with mild to moderate symptoms.
Read More
Lilly India gets nod for use of monoclonal antibody drugs for treating Cov
Updated : 5 years ago IST
New Delhi [India], June 1 (ANI): Eli Lilly and Company India said on Tuesday it has received permission for restricted emergency use of its antibody drugs bamlanivimab 700 mg and etesevimab 1,400 mg in India for treatment of patients with mild to moderate coronavirus disease 2019 (Covid-19).
Read More
Lilly signs pact with Natco to accelerate availability of baricitinib for
Updated : 5 years ago IST
New Delhi [India], May 17 (ANI): Eli Lilly and Company said on Monday it has issued an additional royalty-free, non-exclusive voluntary license to Natco Pharma, a local pharmaceutical manufacturer of generic medicines.
Read More
Lilly signs 3 more pacts to accelerate availability of baricitinib for Cov
Updated : 5 years ago IST
New Delhi [India], May 13 (ANI): Eli Lilly and Company said on Thursday it has issued additional royalty-free, non-exclusive voluntary licenses to Dr Reddy's Ltd, MSN Laboratories and Torrent Pharmaceuticals who will collaborate to accelerate and expand the availability of baricitinib in Ind
Read More
Dr Reddy's enters into licensing agreement with Eli Lilly for COVID-19 tre
Updated : 5 years ago IST
Hyderabad (Telangana) [India], May 12 (ANI): Dr Reddy's Laboratories on Tuesday said that it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company for the manufacture and commercialization of the drug baricitinib, in India.
Read More